StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd

Bullboard Posts

Comment by KPOIndustrieson May 05, 2020 3:41pm

75 Views

Post# 30989519

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:FDA

The tests are there, StageZero's lab is not. Why is Exact, the SZLS competitor, on there and approved? Something doesn't add up here. Is that why we are held at this price?

Nailbiter1 wrote: They are not StageZero tests, doof, they are BTNX and THERMO-FISHER TESTS. Look those ones up. Geeeeeeeeez.

KPOIndustries wrote:
I've dug, I've been on the FDA website daily. I don't see anything related to StageZero. So how can they run tests? That's what I'm asking...

PeerReviewed wrote: Do you own digging buddy. I won't encourage a lazzy like you.